2021-02-11 Redwood Pharma will receive approximately SEK 34.2 million through a heavily oversubscribed rights issue Regulatory
2021-01-18 Redwood Pharma announces intention to move to Nasdaq First North Growth Market stock exchange Regulatory
2020-09-08 Redwood Pharma launches new development program for mild dry eye based on its proprietary IntelliGel platform Regulatory
2020-07-23 New patent for the use of estrogens in the treatment of DED to be issued in the US Regulatory